Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06575400
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Randomised Single-blind Placebo-controlled Trial to Assess Safety Tolerability and Pharmacokinetics of Single and Multiple Rising Subcutaneous Doses of BI 3804379 in Healthy Male and Female Subjects
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objectives of this trial are to investigate safety tolerability and pharmacokinetics PKs of BI 3804379 in healthy male and female subjects following administration of single rising doses and administration of multiple rising doses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None